Farther Finance Advisors »

Silverback Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 1.1k 11.65
2025-09-30 $16k 1.5k 10.05
2025-06-30 $8.6k 493 17.45
2025-03-31 $6.7k 536 12.53
2024-12-31 $2.6k 246 10.55
2024-09-30 $87 6 14.50

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Microsoft Corp Stock (MSFT)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Vanguard Value Etf Etf (VTV)

View all positions for Farther Finance Advisors

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
Rubric Capital Management
BlackRock
Sr One Capital Management
Standard Life Aberdeen
Vanguard Group
State Street Corporation
Alliancebernstein
Franklin Resources
UBS Group
Tyro Capital Management
Citadel Advisors
Casdin Capital

View all funds holding Silverback Therapeutics